ANDA 87964, held by USL Pharma. Brompheniramine Maleate.
As of Nov 21, 2026, ANDA 87964 (Brompheniramine Maleate), held by USL Pharma, was first approved by FDA on Jan 25, 1983, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 25, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Brompheniramine Maleate2MG/5ML · elixir;oral | Brompheniramine Maleate | Discontinued |
| Apr 2, 1987 | Supplement 8Manufacturing | Approved | None posted |
| Apr 2, 1987 | Supplement 9Manufacturing | Approved | None posted |
| Jan 25, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters